RespireRx Pharmaceuticals Inc (fka RSPI)

[bladerunner1717]

Dew,

At $.65/share and around a $25 million market cap, would you consider COR a buy here?

What did you make of the announcement of the Tran hiring today? Do you view as a positive?

Where do you see COR moving from here? Where do you expect Stoll to take the company? Indications? Development strategy? Partnerships?

Do you see any hope that COR might get back rights to schizo and depression from Schering for allowing Schering rights of first refusal on any Ampakines that COR might develop for those indications?


Bladerunner